AVIR
NASDAQ · Pharmaceuticals
Atea Pharmaceuticals Inc
$5.60
+0.17 (+3.13%)
Open$5.47
Previous Close$5.43
Day High$5.61
Day Low$5.38
52W High$6.45
52W Low$2.78
Volume—
Avg Volume284.2K
Market Cap418.27M
P/E Ratio—
EPS$-2.09
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+722.3% upside
Current
$5.60
$5.60
Target
$46.05
$46.05
$31.54
$46.05 avg
$64.23
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 49.99M | 49.26M | 44.69M |
| Net Income | 8.60M | 11.50M | 7.45M |
| Profit Margin | 17.2% | 23.3% | 16.7% |
| EBITDA | 12.90M | 12.92M | 13.20M |
| Free Cash Flow | 9.03M | 8.66M | 6.93M |
| Rev Growth | +19.5% | +7.9% | +2.0% |
| Debt/Equity | 0.36 | 0.36 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |